290 related articles for article (PubMed ID: 27288011)
1. Krüppel-Like Factor 15 Mediates Glucocorticoid-Induced Restoration of Podocyte Differentiation Markers.
Mallipattu SK; Guo Y; Revelo MP; Roa-Peña L; Miller T; Ling J; Shankland SJ; Bialkowska AB; Ly V; Estrada C; Jain MK; Lu Y; Ma'ayan A; Mehrotra A; Yacoub R; Nord EP; Woroniecki RP; Yang VW; He JC
J Am Soc Nephrol; 2017 Jan; 28(1):166-184. PubMed ID: 27288011
[TBL] [Abstract][Full Text] [Related]
2. Podocyte-Specific Induction of Krüppel-Like Factor 15 Restores Differentiation Markers and Attenuates Kidney Injury in Proteinuric Kidney Disease.
Guo Y; Pace J; Li Z; Ma'ayan A; Wang Z; Revelo MP; Chen E; Gu X; Attalah A; Yang Y; Estrada C; Yang VW; He JC; Mallipattu SK
J Am Soc Nephrol; 2018 Oct; 29(10):2529-2545. PubMed ID: 30143559
[TBL] [Abstract][Full Text] [Related]
3. The Krüppel-like factor 15-NFATc1 axis ameliorates podocyte injury: a novel rationale for using glucocorticoids in proteinuria diseases.
Dou C; Zhang H; Ke G; Zhang L; Lian Z; Chen X; Zhao X; Chen Y; Li R; Ma J; Li Z; Lin T; Wang W; Ye ZM; Liang X; Shi W; Zhang B; Liu S
Clin Sci (Lond); 2020 Jun; 134(12):1305-1318. PubMed ID: 32478397
[TBL] [Abstract][Full Text] [Related]
4. Kruppel-like factor 15 (KLF15) is a key regulator of podocyte differentiation.
Mallipattu SK; Liu R; Zheng F; Narla G; Ma'ayan A; Dikman S; Jain MK; Saleem M; D'Agati V; Klotman P; Chuang PY; He JC
J Biol Chem; 2012 Jun; 287(23):19122-35. PubMed ID: 22493483
[TBL] [Abstract][Full Text] [Related]
5. Loss of KLF15 accelerates chronic podocyte injury.
Han SS; Yu MY; Yoo KD; Lee JP; Kim DK; Kim YS; Yang SH
Int J Mol Med; 2018 Sep; 42(3):1593-1602. PubMed ID: 29901095
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoids protect and enhance recovery of cultured murine podocytes via actin filament stabilization.
Ransom RF; Lam NG; Hallett MA; Atkinson SJ; Smoyer WE
Kidney Int; 2005 Dec; 68(6):2473-83. PubMed ID: 16316324
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of microRNA-30 facilitates podocyte injury and is prevented by glucocorticoids.
Wu J; Zheng C; Fan Y; Zeng C; Chen Z; Qin W; Zhang C; Zhang W; Wang X; Zhu X; Zhang M; Zen K; Liu Z
J Am Soc Nephrol; 2014 Jan; 25(1):92-104. PubMed ID: 24029422
[TBL] [Abstract][Full Text] [Related]
8. Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies.
Eriguchi M; Yotsueda R; Torisu K; Kawai Y; Hasegawa S; Tanaka S; Noguchi H; Masutani K; Kitazono T; Tsuruya K
Am J Physiol Renal Physiol; 2016 Feb; 310(4):F322-33. PubMed ID: 26632605
[TBL] [Abstract][Full Text] [Related]
9. Fibrinogen links podocyte injury with Toll-like receptor 4 and is associated with disease activity in FSGS patients.
Wang H; Zheng C; Xu X; Zhao Y; Lu Y; Liu Z
Nephrology (Carlton); 2018 May; 23(5):418-429. PubMed ID: 28407405
[TBL] [Abstract][Full Text] [Related]
10. α-Actinin-4 is involved in the process by which dexamethasone protects actin cytoskeleton stabilization from adriamycin-induced podocyte injury.
Liu H; Gao X; Xu H; Feng C; Kuang X; Li Z; Zha X
Nephrology (Carlton); 2012 Nov; 17(8):669-75. PubMed ID: 22804863
[TBL] [Abstract][Full Text] [Related]
11. Krüppel-like factor 15 is a key suppressor of podocyte fibrosis under rotational force-driven pressure.
Yu MY; Kim JE; Lee S; Choi JW; Kim YC; Han SS; Lee H; Cha RH; Lee JP; Lee JW; Kim DK; Kim YS; Yang SH
Exp Cell Res; 2020 Jan; 386(1):111706. PubMed ID: 31697927
[TBL] [Abstract][Full Text] [Related]
12. Ultrastructural features and expression of cytoskeleton proteins of podocyte from patients with minimal change disease and focal segmental glomerulosclerosis.
Shi SF; Wang SX; Zhang YK; Zhao MH; Zou WZ
Ren Fail; 2008; 30(5):477-83. PubMed ID: 18569926
[TBL] [Abstract][Full Text] [Related]
13. Direct Effects of Immunomodulatory Agents on Podocytes in Immune-Mediated Glomerular Diseases.
Manabe S; Nitta K; Nagata M
Contrib Nephrol; 2018; 195():131-142. PubMed ID: 29734158
[TBL] [Abstract][Full Text] [Related]
14. Immunoexpression of podocyte-associated proteins in acquired human glomerulopathies with nephrotic syndrome.
Wagrowska-Danilewicz M; Stasikowska O; Danilewicz M
Pol J Pathol; 2006; 57(1):17-21. PubMed ID: 16739878
[TBL] [Abstract][Full Text] [Related]
15. Pdlim2 is a novel actin-regulating protein of podocyte foot processes.
Sistani L; Dunér F; Udumala S; Hultenby K; Uhlen M; Betsholtz C; Tryggvason K; Wernerson A; Patrakka J
Kidney Int; 2011 Nov; 80(10):1045-54. PubMed ID: 21814175
[TBL] [Abstract][Full Text] [Related]
16. Any value of podocyte B7-1 as a biomarker in human MCD and FSGS?
Novelli R; Gagliardini E; Ruggiero B; Benigni A; Remuzzi G
Am J Physiol Renal Physiol; 2016 Mar; 310(5):F335-41. PubMed ID: 26697986
[TBL] [Abstract][Full Text] [Related]
17. Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis.
Fornoni A; Sageshima J; Wei C; Merscher-Gomez S; Aguillon-Prada R; Jauregui AN; Li J; Mattiazzi A; Ciancio G; Chen L; Zilleruelo G; Abitbol C; Chandar J; Seeherunvong W; Ricordi C; Ikehata M; Rastaldi MP; Reiser J; Burke GW
Sci Transl Med; 2011 Jun; 3(85):85ra46. PubMed ID: 21632984
[TBL] [Abstract][Full Text] [Related]
18. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.
Chen CA; Hwang JC; Guh JY; Chang JM; Lai YH; Chen HC
J Lab Clin Med; 2006 Feb; 147(2):74-82. PubMed ID: 16459165
[TBL] [Abstract][Full Text] [Related]
19. Roles of fluid shear stress and retinoic acid in the differentiation of primary cultured human podocytes.
Yang SH; Choi JW; Huh D; Jo HA; Kim S; Lim CS; Lee JC; Kim HC; Kwon HM; Jeong CW; Kwak C; Joo KW; Kim YS; Kim DK
Exp Cell Res; 2017 May; 354(1):48-56. PubMed ID: 28320523
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone prevents podocyte apoptosis induced by puromycin aminonucleoside: role of p53 and Bcl-2-related family proteins.
Wada T; Pippin JW; Marshall CB; Griffin SV; Shankland SJ
J Am Soc Nephrol; 2005 Sep; 16(9):2615-25. PubMed ID: 15987750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
